RBC Capital Maintains Outperform on Charles River, Raises Price Target to $322
9/25/2026
Impact: 75
Healthcare
RBC Capital analyst Ryan Halsted has maintained an Outperform rating on Charles River (NYSE: CRL) and raised the price target from $282 to $322. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: